Welcome to BioTrends Research Group

Our Mission

BioTrends is the leader in providing specialized, syndicated market research in clinically complex, small to mid-size pharmaceutical markets.

By extension of our syndicated publications, BioTrends partners with clients to provide custom research solutions that allow clients to intimately understand their markets and to make informed business decisions.

 

Recent News

  • Subscribe to Recent News

    BioTrends provides an email subscription service for its news releases 
    Please click the link below to subscribe:
    Subscribe Here



  • January 19, 2010

    DECISION RESOURCES, INC. ACQUIRES BIOTRENDS
    Read more... Link

  • January 11, 2010

    New Report by BioTrends Research Group To Highlight The Launch Of ACTEMRA (tocilizumab)
    Read more... Link

  • January 11, 2010

    Does the MS Market Need Another Interferon?  Neurologists Provide Insight in the Wave One Report of LaunchTrends®: EXTAVIA
    Read more... Link

  • January 7, 2010

    Three Nephrology TreatmentTrends Publications from BioTrends Provide a Comprehensive View of Bone and Mineral Metabolism Practice Patterns Around the Globe
    Read more... Link

  • January 6, 2010

    BioTrends Provides Insight into the Global Renal Anemia Market with the Release of Three Nephrology TreatmentTrends Publications
    Read more... Link

  • December 23, 2009

    BioTrends Publishes New Report Exploring Treatment Patterns for Anemia Across A Variety of Physician Specialties
    Read more... Link